Neuromuscular Junction Blocking Agents Nursing Pharmacology

Generic and Brand Names

• Nondepolarizing NMJ Blockers
• atracurium (Tracrium)
• cisatracurium (Nimbex)
• pancuronium (Pavulon)
• rocuronium (Zemuron)
• vecuronium (Norcuron)
• Depolarizing NMJ Blockers
• succinylcholine (Anectine, Quelicin)

The Neuromuscular Junction

The NMJ is the synapse where a motor neuron communicates with a skeletal muscle fiber to trigger contraction. The sarcomere, the functional unit of muscle, is built from light (actin) and dark (myosin) filaments stacked in the orderly pattern that gives it a striped look. Normal function starts when a nerve impulse reaches the motor nerve terminal and releases the neurotransmitter acetylcholine (ACh) into the synaptic cleft. NMJ blockers interrupt that process, and they come in two types: nondepolarizing and depolarizing.

Nondepolarizing NMJ Blockers

Nondepolarizing blockers act as antagonists to ACh at the NMJ. They occupy the muscular cholinergic receptor site so ACh cannot react with it, the muscle never activates, and flaccid paralysis results. Curare, the first one discovered, was used by hunters as an arrow-tip poison that killed animals through respiratory muscle paralysis but was safe to eat because cooking and gastric acid destroyed it. Purified for clinical use, it became tubocurarine.

Use these as an adjunct to general anesthesia to stop reflex muscle movement during surgery, to facilitate intubation by preventing resistance to the endotracheal tube, and to facilitate ECT, where uncontrolled skeletal muscle contraction from the electric shock could break bones or cause other injury.

Pharmacokinetics

Here are the characteristic interactions of nondepolarizing NMJ blockers and the body in terms of absorption, distribution, metabolism, and excretion:

Contraindications and cautions: allergy; myasthenia gravis (worsened by blocking ACh cholinergic receptors); renal or hepatic disease (impairs metabolism and excretion, risking toxicity); family or personal history of malignant hyperthermia (extreme muscle rigidity, severe fever, acidosis, and death, which can occur with these agents); pulmonary or CV disease (worsened by respiratory muscle paralysis and the resulting perfusion and respiratory changes); altered fluid and electrolyte balance (affects membrane stability and muscle function); and lactation.

Adverse effects: profound and prolonged muscle paralysis, and respiratory paralysis with depressed respiration, bronchospasm, and apnea. Prolonged use brings GI paralysis, constipation, vomiting, regurgitation, and aspiration. Pressure ulcers develop because the patient loses the reflex movement that normally protects the body, and hyperkalemia can occur from muscle membrane changes.

Interactions: halothane has a membrane-stabilizing effect that greatly enhances the induced paralysis; aminoglycoside antibiotics and calcium-channel blockers also increase the block; cholinesterase inhibitors decrease effectiveness (and are the reversal agent); xanthines reverse the neuromuscular block; and alkaline solutions cause precipitate formation.

Depolarizing NMJ Blockers

Depolarizing blockers act as agonists to ACh at the NMJ. Succinylcholine, the only drug in this class, attaches to the ACh receptor on the muscle cell and stays there, causing prolonged depolarization so the cell cannot repolarize and the muscle locks in a constant contracted state. Use it as an adjunct to general anesthesia, to facilitate endotracheal intubation, and to induce skeletal muscle relaxation during surgery or mechanical ventilation. It is the choice when a very short-acting, rapid-onset blocker is needed.

Pharmacokinetics

Here are the characteristic interactions of nondepolarizing NMJ blockers and the body in terms of absorption, distribution, metabolism, and excretion:

Contraindications and cautions match the nondepolarizing list: allergy, myasthenia gravis, renal or hepatic disease, family or personal history of malignant hyperthermia, pulmonary or CV disease, altered fluid and electrolyte balance, and lactation.

Adverse effects: profound and prolonged muscle paralysis, and respiratory paralysis with depressed respiration, bronchospasm, and apnea. The class-defining danger is malignant hyperthermia, with massive muscle contraction, sharply elevated body temperature, and severe acidosis. Succinylcholine is a known trigger and is contraindicated in anyone with a personal or family history of malignant hyperthermia (FDA, Anectine prescribing information). Intravenous dantrolene is the only FDA-approved drug for treating the crisis and works by blocking calcium release from the sarcoplasmic reticulum, so it stays immediately available wherever these agents are used (FDA, Dantrium Intravenous prescribing information). Interactions are the same as for the nondepolarizing agents (halothane, aminoglycosides, calcium-channel blockers, cholinesterase inhibitors, xanthines, alkaline solutions).

Age-Group Considerations

Children require very careful monitoring and support after NMJ blockers, given only by anesthetists skilled in their use with full support services available. Nondepolarizing agents are preferred in children because they avoid the muscle contraction and recovery discomfort, while succinylcholine is preferred when a very short-acting, rapid-onset block is needed. In adults, close monitoring for full return of muscle function is vital, expect muscle pain and discomfort after a succinylcholine procedure, and use NMJ blockers in pregnancy or lactation only when the benefit to the mother outweighs the risk to the fetus or neonate. Older adults more easily reach toxic drug levels from changes in metabolism and excretion, need meticulous skin care to prevent breakdown, and may need longer monitoring with regular orienting and reassurance.

Nursing Considerations

Screen for the cautions and contraindications above (drug allergy, hepatic and renal impairment). Do a thorough physical (weight, neurological status, vital signs, heart sounds, bowel sounds) for baseline, effectiveness, and adverse effects. Inspect skin color and pressure areas, since immobility threatens skin integrity. Monitor liver and renal function for dose reduction and toxicity. Likely diagnoses: impaired gas exchange from depressed respiration, impaired skin integrity from immobility, impaired verbal communication from the effect on muscle activity, and risk for injury from loss of muscle control.

Prepare emergency equipment to maintain the airway and provide mechanical ventilation. Give skin care at the administration site to reduce breakdown. Monitor temperature for prompt detection and treatment of malignant hyperthermia. Keep a cholinesterase inhibitor available to overcome excessive blockade from nondepolarizing agents. Add comfort and safety measures (lighting, raised side rails) and teach the regimen.

Evaluate by monitoring the response to therapy (adequate muscle paralysis), watching for adverse effects (respiratory depression, hypotension, bronchospasm, GI slowdown, skin breakdown), confirming the patient can name the drug and its effects once recovered, and checking compliance.

Frequently Asked Questions

What is the difference between depolarizing and nondepolarizing NMJ blockers? Nondepolarizing agents (atracurium, vecuronium, rocuronium, and others) block the acetylcholine receptor so the muscle never activates, producing flaccid paralysis. Succinylcholine, the only depolarizing agent, occupies the receptor and keeps the muscle depolarized so it cannot repolarize, with a very short, rapid-onset block.

Why is airway and ventilation support the whole job with these drugs? They paralyze skeletal muscle, including the muscles of respiration, so the patient cannot breathe on their own. Emergency airway equipment and mechanical ventilation must be ready before the dose, with continuous monitoring until full muscle function returns.

How is a nondepolarizing block reversed? A cholinesterase inhibitor (such as neostigmine) increases acetylcholine at the junction to overcome the block, so one stays available whenever a nondepolarizing agent is given. Succinylcholine is not reversed this way because its mechanism is the opposite.

What is malignant hyperthermia and how is it treated? It is a rare, life-threatening reaction of massive muscle contraction, soaring body temperature, and severe acidosis. Succinylcholine is a known trigger, so monitor temperature closely; intravenous dantrolene is the only FDA-approved treatment and must be on hand (FDA, Dantrium Intravenous prescribing information).

Who should not receive succinylcholine? It is contraindicated in anyone with a personal or family history of malignant hyperthermia, and it is cautioned in myasthenia gravis, renal or hepatic disease, and altered fluid and electrolyte balance (FDA, Anectine prescribing information).

Why does skin care matter so much during paralysis? The patient loses the reflex movement that normally shifts pressure off bony areas, so pressure ulcers form quickly. Inspect pressure points and give meticulous skin care, especially in older adults and during prolonged use.